Heartware International (HTWR)

Add to Watchlists Create an Alert
92.67 -0.14  -0.15%   NASDAQ May 23, 4:59PM BATS Real time Currency in USD
View Full Chart
HTWR Price Chart
    View All Performance Charts

    HTWR Total Returns Comparison

    This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Heartware International is up 18.40% over the last year vs S&P 500 Total Return up 28.33%, Thoratec Corporation up 0.93%, and Accuray down 14.40%.

    HTWR Fundamentals

    Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

    Income Statement View Statement

    Balance Sheet View Statement

    Total Assets 338.05M
    Liabilities 136.04M
    Get Quote for

    Pro Report PDF for HTWR

    Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

    Download HTWR Pro Report PDF

    Pro Strategies Featuring HTWR

    Did Heartware International make it into our Pro Portfolio Strategies?

    Start your YCharts Pro membership now to find out.

    HTWR Profile

    Sector: Healthcare
    Industry: Medical Devices

    HeartWare International, Inc. is a medical device company developing a family of implantable Left Ventricular Assist Devices ("LVADs") for the treatment of advanced heart failure. The HeartWare Ventricular Assist System which includes a left ventricular assist device or blood pump, patient accessories and surgical tools that is designed to provide circulatory support for patients in the advanced stage of heart failure. Its core System is a proprietary continuous flow blood pump, the HVAD Pump, which is a full-output device capable of pumping up to 10 liters of blood per minute. The HeartWare System is designed to be implanted adjacent to the heart, avoiding the abdominal surgery generally required to implant similar devices. HeartWare International, Inc. sells and markets its products through clinical studies in the United States, as well as directly to cardiac centers and hospitals internationally. The company was founded on July 29, 2008 and is headquartered in Framingham, Massachusetts.

    Recent Quotes

    Symbol Price Chg Chg % Market Cap
    HTWR 92.67 -0.14 -0.15% 1.515B
    New watchlist
    Create
    Success.

    Your new watchlist has been created

    View WatchlistsDone
    Create Watchlist from Quotes

    Register for your Free YCharts Account.

    Understand your investments with more data than any other free site.

    • Create watchlists that you care about for stocks or economic indicators
    • Create alerts to track the movements of your stocks
    • Access stock analysis from our in-house experts
    Get Started Now

    Already registered? Sign in to your account.

    document.write('');